首页> 外文期刊>Infection and immunity >Pathophysiology of Antigen 85 in Patients with Active Tuberculosis: Antigen 85 Circulates as Complexes with Fibronectin and Immunoglobulin G
【24h】

Pathophysiology of Antigen 85 in Patients with Active Tuberculosis: Antigen 85 Circulates as Complexes with Fibronectin and Immunoglobulin G

机译:活动性肺结核患者中抗原85的病理生理学:抗原85与纤连蛋白和免疫球蛋白G形成复合体循环

获取原文
获取外文期刊封面目录资料

摘要

Antigen 85 (Ag85) complex proteins are major secretory products ofMycobacterium tuberculosis and induce strong cellular and humoral immune responses in infected experimental animals and human beings. We have previously shown that nanogram doses of these 30- to 32-kDa fibronectin-binding proteins inhibit local expression of delayed hypersensitivity by a T-cell fibronectin-dependent mechanism. Circulating levels of Ag85 might be expected to be elevated in patients with active tuberculosis and possibly to play a role in systemic anergy in these patients. To test this hypothesis, Ag85 was measured in serum and urine by a monoclonal antibody-based dot immunobinding assay in 56 patients and controls with known skin test reactivity. Median serum Ag85 levels were 50- to 150-fold higher in patients with active tuberculosis than in patients with active M. avium-intracellulare disease or other nontuberculous pulmonary disease or in healthy controls (P < 0.001). The median and range of serum Ag85 in patients with active tuberculosis was not significantly different between skin test-positive and -negative subjects. Patients with active M. aviumdisease could be distinguished from those with disease due to M. tuberculosis by monoclonal anti-Ag85 antibodies of appropriate specificities. No increases in urinary Ag85 were detected in any patient, regardless of the Ag85 level in serum. Chromatographic analysis and immunoprecipitation studies of serum revealed that Ag85 existed in the serum of these patients complexed to either fibronectin or immunoglobulin G (IgG). Uncomplexed circulating Ag85 was demonstrable in serum from fewer than 20% of patients with active tuberculosis. In patients with active tuberculosis, Ag85 is therefore likely to circulate primarily as complexes with plasma fibronectin and IgG rather than in unbound form. The existence of Ag85 complexes with plasma proteins would account for its lack of urinary clearance.
机译:抗原85(Ag85)复合蛋白是结核分枝杆菌的主要分泌产物,可在感染的实验动物和人类中诱导强烈的细胞和体液免疫反应。以前我们已经表明,这些30-32kDa纤连蛋白结合蛋白的纳克剂量通过T细胞纤连蛋白依赖性机制抑制迟发型超敏反应的局部表达。患有活动性肺结核的患者可能会升高Ag85的循环水平,并可能在这些患者的全身性无反应中发挥作用。为了检验这一假设,对56名患者和具有已知皮肤测试反应性的对照组进行了基于单克隆抗体的斑点免疫结合测定,以测定血清和尿液中的Ag85。活动性结核病患者的血清中血清Ag85水平比活动性 M患者高50至150倍。禽细胞内疾病或其他非结核性肺部疾病或健康对照( P <0.001)。皮肤测试阳性和阴性受试者在活动性肺结核患者中血清Ag85的中位数和范围无显着差异。活动性 M的患者。鸟病可以与 M引起的疾病区分开来。单克隆抗体具有适当的特异性。无论血清中的Ag85水平如何,在任何患者中均未检测到尿中Ag85的升高。血清的色谱分析和免疫沉淀研究表明,这些患者的血清中存在与纤连蛋白或免疫球蛋白G(IgG)复合的Ag85。在少于20%的活动性肺结核患者中,血清中可显示出无复杂循环的Ag85。因此,在活动性肺结核患者中,Ag85可能主要以与血浆纤连蛋白和IgG的复合物而不是未结合的形式循环。 Ag85与血浆蛋白复合物的存在将解释其缺乏尿清除率的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号